Holy Stone Healthcare Co., Ltd. (TPEX:4194)
Taiwan · Delayed Price · Currency is TWD 8.47
-0.17 (-2.01%)
Apr 20, 2026, 1:24 PM CST
Holy Stone Healthcare Market Cap
Holy Stone Healthcare has a market cap or net worth of 1.24 billion as of April 20, 2026. Its market cap has decreased by -14.83% in one year.
Market Cap
1.24B
Enterprise Value
1.11B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.47
Market Cap Chart
Since December 13, 2013, Holy Stone Healthcare's market cap has decreased from 5.54B to 1.24B, a decrease of -77.62%. That is a compound annual growth rate of -11.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 1.24B | 10.39% |
| Dec 31, 2025 | 1.12B | -40.54% |
| Dec 31, 2024 | 1.89B | -21.47% |
| Dec 29, 2023 | 2.41B | -36.56% |
| Dec 30, 2022 | 3.79B | 20.29% |
| Dec 30, 2021 | 3.15B | 17.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenMont Biotech Incorporation | 1.54B |
| Advagene Biopharma | 1.53B |
| NeoCore Technology | 1.40B |
| Abnova (Taiwan) | 1.36B |
| Enimmune | 1.34B |
| Great Novel Therapeutics Biotech & Medicals | 1.33B |
| Meribank Biotech | 1.16B |
| GeneReach Biotechnology | 1.13B |